Interruption of CXCL13-CXCR5 Axis Increases Upper Genital Tract Pathology and Activation of NKT Cells following Chlamydial Genital Infection by Jiang, J. et al.
Interruption of CXCL13-CXCR5 Axis Increases Upper
Genital Tract Pathology and Activation of NKT Cells
following Chlamydial Genital Infection
Janina Jiang1., Ouafae Karimi4., Sander Ouburg4, Cheryl I. Champion1, Archana Khurana6,
Guangchao Liu1, Amanda Freed1, Jolein Pleijster7, Nora Rozengurt1,3, Jolande A. Land7,
Helja-Marja Surcel8, Aila’ Tiitinen9, Jorma Paavonen9, Mitchell Kronenberg6, Servaas A. Morre´4,5,
Kathleen A. Kelly1,2*
1Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of
America, 2California NanoSystems, University of California Los Angeles, Los Angeles, California, United States of America, 3CURE DDRC Morphology and Images Core,
University of California Los Angeles, Los Angeles, California, United States of America, 4 Laboratory of Immunogenetics, Department of Medical Microbiology and Infection
Control, VU University Medical Center, Amsterdam, The Netherlands, 5 Institute of Public Health Genomics, Department of Genetics and Cell Biology, Research Institutes,
School of Public Health and Primary Care (CAPHRI) and Growth and Development (GROW), Faculty of Health, Medicine & Life Sciences, University of Maastricht, Maastricht,
The Netherlands, 6 La Jolla Institute for Allergy and Immunology, La Jolla, California, United States of America, 7Department of Obstetrics and Gynaecology, University
Medical Center Groningen, Groningen, The Netherlands, 8National Institute for Health and Welfare, Kastelli Research Centre, Oulu, Finland, 9Department of Obstetrics
and Gynecology, University Hospital, University of Helsinki, Helsinki, Finland
Abstract
Background: Regulation of immune responses is critical for controlling inflammation and disruption of this process can lead
to tissue damage. We reported that CXCL13 was induced in fallopian tube tissue following C. trachomatis infection. Here, we
examined the influence of the CXCL13-CXCR5 axis in chlamydial genital infection.
Methodology and Principal Findings: Disruption of the CXCL13-CXCR5 axis by injecting anti-CXCL13 Ab to BALB/c mice or
using Cxcr52/2 mice increased chronic inflammation in the upper genital tract (UGT; uterine horns and oviducts) after
Chlamydia muridarum genital infection (GT). Further studies in Cxcr52/2 mice showed an elevation in bacterial burden in
the GT and increased numbers of neutrophils, activated DCs and activated NKT cells early after infection. After resolution,
we noted increased fibrosis and the accumulation of a variety of T cells subsets (CD4-IFNc, CD4-IL-17, CD4-IL-10 & CD8-
TNFa) in the oviducts. NKT cell depletion in vitro reduced IL-17a and various cytokines and chemokines, suggesting that
activated NKT cells modulate neutrophils and DCs through cytokine/chemokine secretion. Further, chlamydial glycolipids
directly activated two distinct types of NKT cell hybridomas in a cell-free CD1d presentation assay and genital infection of
Cd1d2/2 mice showed reduced oviduct inflammation compared to WT mice. CXCR5 involvement in pathology was also
noted using single-nucleotide polymorphism analysis in C. trachomatis infected women attending a sub-fertility clinic.
Women who developed tubal pathology after a C. trachomatis infection had a decrease in the frequency of CXCR5 SNP
+10950 T.C (rs3922).
Conclusions/Significance: These experiments indicate that disruption of the CXCL13-CXCR5 axis permits increased
activation of NKT cells by type I and type II glycolipids of Chlamydia muridarum and results in UGT pathology potentially
through increased numbers of neutrophils and T cell subsets associated with UGT pathology. In addition, CXCR5 appears to
contribute to inter-individual differences in human tubal pathology following C. trachomatis infection.
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Introduction
Chlamydia trachomatis, an obligate intracellular bacterium, causes
the most cases of bacterial sexually transmitted infections (STIs) in
the US resulting in about three million new cases annually [1–3].
Genital infection can lead to immune-mediated damage of the
female reproductive organs and serious reproductive disability,
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including pelvic inflammatory disease (PID) that can result in
chronic pelvic pain, ectopic pregnancy and infertility. Approxi-
mately 8% of females annually develop PID and this risk increases
by 40–70% following re-infection [3,4]. Although female infection
is easily detected and treated with antibiotics, treated individuals
can acquire another infection in six months implicating repeated
inflammatory insults as a cause of PID and infertility [5].
However, the mechanism(s) which causes PID and infertility
following chlamydial genital infection is not known.
The mouse model of C. trachomatis genital infection (C. muridarum)
is used to reveal the underlying mechanism(s) for developing
immune-mediated damage of the female reproductive organs
following STIs. It is known that C. muridarum bacteria cause genital
tract (GT) infections which trigger development of protective
immune responses but infection also results in GT inflammation
and is associated with neutrophils and CD8 cells that produce
TNFa [6–8]. Immune-mediated damage can be quantitated in the
mouse, is a measure of infertility and is termed upper genital tract
(UGT) pathology [9]. The majority of genital infections are
resolved by development of an anti-chlamydial Th1 response
[10,11].
NKT cells are innate-like T cells that rapidly respond to
infection and regulate microbial immunity including C. muridarum
lung and GT infection [12–15]. NKT cells require TCR ligation
for activation to secrete an array of cytokines and chemokines
[16,17]. In addition, they also modulate immune outcomes by
interacting with dendritic cells (DC), NK cells, T, B cells and
plasmacytoid DC by cell-cell contact [12]. NKT cells are activated
with CD1d-restricted glycolipid antigens and are classified into
two subsets [16,18]. Type I (classical or invariant, iNKT) NKT
cells express an invariant TCR, Va14-Ja18 in the mouse and the
homolog, Va24-Ja18, in humans [19]. The antigen receptors
expressed by iNKT cells in mice and humans recognize exogenous
glycolipids expressed by microbes that contain a common
glycolipid structure, including the GLXA glycolipid of C. muridarum
[13]. Type II NKT cells are less studied than iNKT cells, have a
more diverse in TCR repertoire and do not recognize the
prototypical iNKT cell activating antigen, a-galactosylceramide
(a-GalCer) [19].
Chemokines have an established role in homing and directional
migration but also have additional roles in the immune system
including; development of lymphoid organs, cognate interaction,
cell signaling, differentiation, cell survival and serve as growth
factors. Likewise, the chemokine CXCL13 has additional roles
beyond migration and disruption of the CXCL13-CXCR5 axis
occurs in many diseases as well as chronic infections [20–23]. We
recently reported that C. trachomatis induces expression of
CXCL13, the ligand for CXCR5, in human fallopian tube tissue
following infection [24]. Surprisingly, the mRNA for this
chemokine was induced at higher levels (30-fold over mock
infected controls) in comparison to more than 90 other cytokines
and chemokines analyzed including IFNc. In this report, we
examined the influence of the CXCL13-CXCR5 axis in
chlamydial genital infection.
Materials and Methods
Ethics Statement
All experimental animal procedures were approved by the
UCLA Office of Animal Research Oversight; Chancellor’s Animal
Research Committee which adheres to the national guidelines
with the Public Health Service Policy on Human Care and Use of
Animals (PHS Policy) and USDA Animal Welfare Regulation
(AWRs) with assurance number A3196. All procedures were
designed to provide for maximum comfort/minimal stress to the
animals and cannot be further refined to minimize pain/distress
since there are no less painful/distressful options available. The
procedures are presently refined to provide the best possible
scientific methodologies available. The animals are monitored for
signs of agitation (licking, biting or guarding the vaginal region),
failure to groom, loss of appetite, or marked weight loss (.10%). If
noted, the Attending Veterinarian is contacted for his/her
recommendation for treatment. Human subjects analyzed for
CXCR5 SNP typing were consented by a written informed
consent form and approved by review boards at Vrije Universiteit,
Amsterdam, The Netherlands and University of Helsinki.
Animals, Chlamydia, anti-CXCL13 treatment and
Challenge of mice
BALB/c and C57BL/6 mice (Jackson Labs, Bar Harbor,
Maine) or a breeding colony was established with Cxcr52/2 mice
(8 generations in C57BL/6) obtained from Martin Lipp,
Delbru¨ck-Center for Molecular Medicine, Berlin, Germany.
BALB/c mice were given two intraperitoneal injections of affinity
purified goat IgG anti-CXCL13 or control goat IgG (R&D
Systems, Minneapolis, Minn) on days 21 and 2 of infection [25].
Chlamydia muridarum was grown on confluent McCoy cell mono-
layers, purified on Renograffin gradients and stored at 280uC in
SPG buffer (sucrose-phosphate-glutamine) as previously described
[26]. Mice were hormonally synchronized by subcutaneous
infection with 2.5 mg of medroxyprogesterone acetate (Depo
Provera, Upjohn, Kalamazoo, MI) in 100 mL saline 7 days prior to
a vaginal challenge with 1.56105 IFUs of C. muridarum under
anesthetization. Mice were 5–6 weeks old at the time of infection.
Infection was monitored by measuring infection forming units
(IFU) from cervical–vaginal swabs (Dacroswab Type 1, Spectrum
Labs, Rancho Dominguez, CA) as previously described [27].
Histology, Hematoxylin & Eosin and Trichrome stain
GT’s were removed at day 49 post-infection, fixed in 10%
formalin overnight, and subsequently, 70% ethanol. Tissues were
embedded en bloc in paraffin, sectioned (5 mm), and stained with
hematoxylin and eosin. A second set was stained with hematoxylin
and eosin followed by Gormori trichrome [28]. Two hematoxylin
and eosin (H&E) sections per mouse were masked and scored for
chronic inflammatory cells or mononuclear cells [29]: 0 = normal,
1 = rare foci, 2 = scattered (1 to 4) aggregates, 3 = numerous
aggregates (.4), 4 = severe diffuse infiltration. Two slides were
scored and averaged per oviduct. Trichrome stained slides were
used to access fibrosis and were masked and counted using the
following scoring scheme: 1+= bright blue staining collagen fibers
surrounding ,33% of oviducts; 2+= bright blue staining collagen
fibers surrounding 34–66% of oviducts; 3+= bright blue staining
collagen fibers surrounding .66% of oviducts. Naı¨ve mice score
from 1–2+. Two slides were scored and averaged per oviduct.
Lympholyte isolation and FACS identification
Spleen (Spl), iliac lymph nodes (ILN), GTs or oviducts were
harvested from individual mice and single cell suspensions
prepared by dissociating the lymphocytes. Lymphocyte isolation
from GTs or oviducts was carried out as described [30]. Briefly,
the entire GT or oviduct was removed and cut into 0.5 cm pieces
that were then rinsed with Ca2+Mg2+-free Hanks’ balanced salt
solution (HBSS). The tissue was incubated in a mixture of 5 mM
EDTA in HBSS at 37uC for two 15 min periods with gentle
stirring. The tissue was then incubated with RPMI 1640
containing 2% bovine calf serum, antibiotics, 25 mM HEPES
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and 1.5 mg/mL collagenase (Sigma, USA) and incubated at 37uC
with stirring for two periods of 1 hr. The isolated cells were pooled
together and separated on a 40/75% discontinuous Percoll
gradient (Pharmacia, Piscataway, N.J.) centrifuged at 2000 rpm
at 22uC for 20 min. Mononuclear cell pellets were resuspended in
RPMI 1640 at 4uC until used. For intracellular cytokine staining,
lymphocytes isolated from different organs were incubated in
RPMI 1640 in the presence of PMA and ionomycin. Brefeldin A
(Sigma) was added 4 hr before the end of culture. For surface
staining, cells were directly stained with various FACS antibodies
after isolation and without in vitro culture. The cells were then
stained with fluorochrome-labeled antibodies against CD3 (clone
145-2C11), CD4 (clone GK1.5), CD8 (clone 53-6.7), Gr-1 (clone
RB6-8C5), NK1.1, (clone PK136), CD11c (clone N418), CD19
(clone 6D5), CD11b (clone…M1/70), CD40 (clone 3/23), CD69
(clone H1.2F3) and CXCR5 (clone 2G8) (Biolegend) and a-
GalCer-CD1d-tetramer for 20 min on ice [31]. After being
washed, the cells were incubated with Cytofix/Cytoperm (BD
Biosciences) for 1 hr and the stained with fluorochrome-conjugat-
ed anti-IFN-c (clone XMG1.2), IL-10 (clone ES5-16E3), TNFa
(clone MP6-XT22) or IL-17 (clone TC11-18H10.1) antibody
(Biolegend) for 20 min on ice, washed again, resuspended in Cell
Fix solution, and analyzed on SORP BD LSR II (Beckman
Dickinson, Franklin Lakes, NJ).
NKT cell depletion, CD1d blocking and in vitro cell
culture
Spleens were treated with iNKT depletion, CD1d blocking,
iNKT depletion+CD1d blocking, or with a-GalCer (250 ng/mL)
and untreated cells served as control. To deplete iNKT cells,
splenocytes were stained with PE-a-GalCer-CD1d-tetramer on ice
for 30 min and the stained iNKT cells were depleted by using
EasySep Mouse EP Positive Selection Kit (Stemcell Technologies,
Canada) according to manufacturer’s protocol. The depletion
efficiency was greater than 90% as tested by FACS analysis. To
deplete CD1d presenting cells, the cells were treated with anti-
CD1d monoclonal antibody (clone 1B1) (10 mg/mL) or isotype
control for 30 min prior to culture. Cells were then cultured in
RPMI 1640 in presence of C. muridarum EB for 3 days and
supernatants were stored at 280uC.
Cytokine measurement and multi-analyte ELISArray
IFNc was measured by ELISA (R&D Systems) in supernatants
from cell cultures following storage 280uC. IL-1b, IL-12, IL-6,
CCL3, CCL4, CCL2, IL-17a, CXCL12, CCL22, CCL5 and
TNFa were analyzed by multi-analyte ELISArray kit (SABios-
ciences, Frederick, MD) in supernatants from cell cultures
following storage 280uC. The assays were carried out according
to manufacturer’s protocol and calibrated standards were provided
by the manufacturer.
In vitro CD1d presentation assay
We used the method of Kinjo et. al. [32] and first coated a 96-
well flat bottom plate with soluble mCD1d protein for 1 h at 37uC.
After washing and blocking, various concentrations of sonicated C.
muridarum was added to wells and incubated for 24 h at 37uC. a-
GalCer and vehicle served as positive and negative controls,
respectively. The wells were washed and 56104 murine invariant
NKT hybridoma cells: 1.2, 1.4, or variant NKT hybridoma 19
were added and cultured overnight (16–20 hr). IL-2 released in
the supernatant upon activation was measured by ELISA (BD
Pharmingen).
Patients
Dutch STD cohort. Women of Dutch Caucasian origin
(n = 543) visiting the STD outpatient clinic in Amsterdam, the
Netherlands during the period of July 2001–December 2004.
Participants were asked to sign an informed consent and fill out a
questionnaire, regarding their complaints at that moment,
varying from increased discharge, having bloody discharge
during and/or after coitus, recent abdominal pain (not gastro-
intestinal or menses related) and/or dysuria. A cervical swab was
taken for the detection of C. trachomatis-DNA by PCR [33].
Peripheral venous blood was collected for the analysis of IgG
antibodies against C. trachomatis (Medac Diagnostika mbH,
Hamburg, Germany). A titre of $1:50 was considered positive.
Those who had no Chlamydia infection, based on negative C.
trachomatis-DNA and without C. trachomatis serology, served as
controls. Infections with Candida albicans, Neisseria gonorrhoea,
Trichomonas vaginalis and Herpes simplex virus 1 or 2 were also
documented. Microorganism detection was done according to
methods described by Ouburg et al. [34].
Dutch Subfertility cohort. The study cohort included 259
Dutch Caucasian women who presented with subfertility at the
Research Institute Growth and Development and the Department
of Obstetrics and Gynaecology, University of Maastricht, The
Netherlands, as part of a larger study. This subfertility group has
been described elsewhere [34,35]. For this study, women with or
without clinically defined tubal pathology (n = 56) were selected to
have the clearest clinical definition. Tubal pathology was defined
as extensive periadnexal adhesions and/or distal occlusions of one
or both tubes. Chlamydial antibodies were assessed by indirect
microimmunofluorescence (MIF) test for anti-C. trachomatis IgG-
antibodies. A positive CT IgG MIF test was defined as a titer
$1:32.
Finland study population. The study population consisted
of 114 infertile women who had attended the In Vitro Fertilization
Unit, Department of Obstetrics and Gynaecology, Helsinki
University Hospital, Helsinki, Finland in 1990–2005. Controls
were selected from a group of 176 female blood donors. The
selected cases consisted of 24 C. trachomatis-positive women with
laparoscopically verified tubal factor infertility (TFI) for the best
clinical definition. The other women, the control group -
consisted of female blood donors whose buffy coat specimens
were provided by the Finnish Red Cross Blood Transfusion
Service (Oulu, Finland). The specimens were transported to the
laboratory at room temperature within 24 h of donation. The
specific immune responses of C. trachomatis have been described
elsewhere and C. trachomatis status was determined by C.
trachomatis specific serology and cell stimulation as described
previously [36].
Cxcr5 SNP detection. Genomic DNA was extracted from
peripheral blood using the MagNaPure LC isolator as described
[34]. A healthy Dutch Caucasian control group (n = 130) was
included to assess the general frequency of the three studied SNPs
CXCR5 +3439 C.T (rs497916), +9086 T.C (rs12363277),
+10950 T.C (rs3922) in the general Dutch Caucasian population.
The CXCR5 SNPs were determined using the standard TaqMan
analysis. The three CXCR5 SNPs tag 96.6% of the haplotypes,
consisting of rs497916, rs566416, rs543524, rs12363277,
rs613791, rs598207, rs3922, and rs676925. This haplotype spans
7 KB of the cxcr5 gene.
Statistics. Bonferroni’s modified t-test and analysis of vari-
ance (ANOVA) was performed using GraphPad Prizm version
5.04, GraphPad Software (San Diego, CA). Groups were
considered statistically different at *p,0.05 and **p,0.01. Data
are presented as mean 6 SD or SEM as indicated. Differences in
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human CXCR5 genotype and haplotype distributions were
analyzed using x2 and Fisher Exact test, where appropriate and
p,0.05 was considered statistically significant. CXCR5 haplotypes
were inferred using PHASE v2.1.1 and SNPHAP.
Results
Disruption of the CXCL13-CXCR5 axis alters bacterial
burden in Cxcr52/2 mice
We evaluated the chlamydial burden in the GT from vaginal
swabs by using two models for disrupting the CXCL13-CXCR5
axis. In the first model, we blocked ligation of CXCL13 with its
receptor, CXCR5, by administering anti-CXCL13 as reported
[25]. As shown in Figure 1A, mice were given 200 mg of polyclonal
goat anti-CXCL13 and irrelevant polyclonal goat Ab the day prior
to infection (d-1) and 2 days after infection (red arrows). This
regimen did not produce any statistical difference in the course of
infection between the groups although we noted that anti-
CXCL13 treated mice cleared infection a few days earlier than
controls. This procedure does not show depletion of CXCL13 in
ELISA assays (data not shown) and there is no assay to detect
functional blocking in vivo [25]. We also examined Cxcr52/2 mice
and found that there was a slight delay in resolution of infection
and a significant increase in bacterial burden during the infection
course compared to WT controls (Fig. 1B). Consistent with the
increased bacterial burden we also found increases in early
immune responders such as neutrophils, activated CD40+
conventional DC (cDC) and activated CD69+ NKT cells in the
GT (Fig. 1C–E) but no difference was seen in the number of
plasmacytoid DC cells (data not shown) which also responds to C.
muridarum genital infection [37]. Cxcr52/2 mice lack Peyer’s
patches, axillary, inguinal, parathymic, mediastinal and iliac
lymph nodes but have facial, cervical, mesenteric lymph nodes
and spleen [38,39]. Possibly, the lack of iliac lymph nodes could
delay the appearance of Th1 cells in the GT and also effect
bacterial load. In support, we found that C. muridarum responsive
Th1 cells peak earlier on day 7 in WT mice compared to day 14 of
Cxcr5/2 mice (Fig. 1F).
Disruption of the CXCL13-CXCR5 axis increased UGT
pathology
We evaluated UGT (uterine horns+oviducts) pathology in mice
treated with anti-CXCL13 Ab and Cxcr52/2 mice by examining
inflammatory scores in the UGT from hematoxylin and eosin
stained slides and fibrosis from trichrome stained slides of oviducts
after infection. Mice treated with anti-CXCL13 Ab and Cxcr52/
2 mice had increased chronic inflammatory or mononuclear cell
scores when harvested 49 days after infection (Fig. 2A). We also
measured the amount of fibrosis seen in mesenchymal tissue from
WT and Cxcr52/2 mice. The mesenchymal tissue surrounding
oviducts from WT mice developed varying degrees of fibrosis after
infection (asterisk) which was increased in Cxcr52/2mice (arrows)
(Fig. 2B). Marked fibrosis was also apparent in all Cxcr52/2 mice
following infection (Fig. 3C). Although we did not note occluding
fibrosis which is associated with infertility, oviduct dilation was also
noted in Cxcr52/2 (arrowhead)(Fig. 2B).
T cell subsets accumulate in the oviducts of Cxcr52/2
mice following infection
After chlamydial genital infection had resolved, we performed
flow cytometry on CD4 and CD8 lymphocyte subsets from
oviducts of Cxcr52/2 and WT mice to identify the type of
accumulating mononuclear cells. Figure 3A shows representative
dotplots of the subsets analyzed. We found a significant increase in
all lymphocyte subsets analyzed in Cxcr52/2 mice which include;
CD4-IFN-c, CD4-IL-17, CD4-IL-10 and CD8-TNF-a (Fig. 4B).
Larger increases were noted in CD4-IL-10 and CD8-TNFa
subsets than the Th1 subset. Thus, mice lacking the CXCR5
chemokine receptor sustain a chronic infiltrate of a variety of T
cell subsets. The CD4-IL-10 and CD8-TNFa subsets have been
associated with reduced chlamydial clearance or oviduct pathol-
ogy, respectively [8,40]. These data suggest that increased
numbers of activated cDC result in increased numbers of T cells
in the GT.
The lack of CXCR5 causes increased cytokine production
by NKT cells
NKT cells respond as innate-like T cells within infected tissues
by secreting an array of cytokines and chemokines upon TCR
activation which results in the recruitment and/or activation of
various immune cells including neutrophils and cDCs. This could
possibly explain the increased neutrophil and activated cDC
numbers seen in the GT of Cxcr52/2 4 days after infection
(Fig. 1C–E) [12]. We tested this by activating splenocytes in vitro
with chlamydiae elementary bodies (EBs). Using IFN-c production
as a marker of early NKT cell activation, we found that splenic
cultures from Cxcr52/2 mice produced approximately 10-fold
greater amounts of IFN-c compared to cultures from WT mice
(Fig. 4A). We then used various means to deplete cultures of NKT
cells in order to determine if NKT cells were the source of
increased IFN-c. Depletion of iNKT cells using the a-GalCer-
CD1d tetramer, depleted greater than 90% of type I NKT cells
and significantly diminished IFN-c production. Stimulation with
a-GalCer increased production of IFN-c above that of WT cells
and demonstrated that iNKT cells contribute in part, to the
increased IFN-c production. We examined IFNc production from
all NKT cells by blocking CD1d antigen presentation with anti-
CD1d antibody. This further reduced IFN-c levels. In addition,
the combination of both treatments reduced IFN-c production
from Cxcr52/2 splenocytes to that of untreated WT control
splenocyte cultures following incubation with C. muridarum EB
which indicates that the majority of the IFNc secreted by
splenocytes in response to EB stimulation was secreted by iNKT
and type II NKT cells (Fig. 4A).
We analyzed other cytokine and chemokines in the splenic
cultures of Cxcr52/2 and WT cells stimulated with EB and
found they produced a variety of inflammatory cytokines and
chemokines that are found in the GT and that attract neutrophils
(IL-17a) and cDC (CXCL12: ligand for CXCR4; CCL3 &
CCL5: ligand for CCR5; CCL2: ligand for CCR2) [41,42].
Cultures from Cxcr52/2 mice produced a 2 to 10-fold increase
in the level of most of cytokines and chemokines analyzed
(Fig. 4B). We then examined supernatants depleted with a-
GalCer-tetramer and blocked with anti-CD1d antibody (desig-
nated ‘‘treated’’ groups) to deplete all NKT cells. We found that
the combination of depletion+blocking of CD1d function reduced
cytokines and chemokine levels which were found to be at or
below that of WT cultures (Fig. 4B). Only secretion of IL-6 was
partially reduced by NKT cell depletion. Increased cytokine and
chemokine levels we observed here could be produced directly by
activated NKT cells or their interaction with other cell types,
such as dendritic cells, as shown by others [43]. These data
suggest that C. muridarum activates NKT cells which recruits early
inflammatory cells, particularly neutrophils and activated cDC to
the GT.
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Figure 1. Disruption of the CXCL13-CXCR5 axis alters bacterial burden in Cxcr52/2 mice. Vaginal swabs were collected throughout the
course of infection in BALB/c mice given i.p. injections (day 21 and 2, red arrow) of anti-CXCL13 Ab or irrelevant control Ab. Not significant by 2-way
repeated measures ANOVA, n= 3/grp. (B) Vaginal swabs were collected throughout the course of infection in Cxcr52/2 and WT mice. *p,0.05 by 2-
way repeated measures ANOVA, n = 11/grp. Experiments were and repeated 5 times. (C–E) Single cell suspensions of whole GT lymphocytes were
stained for flow cytometric identification of neutrophils (Gr-1+ & CD11b+); cDC (CD11c+, CD11b+, CD32, CD192 CD40+) and activated NKT cells (a-
GalCer tetramer, NK1.1+, CD3+; CD69+). Dotplots were gated on singlet lymphocytes and the above markers. Bar graphs show the percent of
neutrophils, CD40+cDC and CD69+NKT over the indicted denominator 6 SD in GT. *p,0.01 as determined by Bonferroni’s t-test, n = 4 pools of two
mice/group. (F) Mice were vaginally infected with C. muridarum and lymphocytes were isolated at various times following infection from the whole
GT. Cells were stimulated ex vivo with PMA and ionomycin and characterized by flow cytometry. Dotplots were gated on CD3 and CD4. Bars show the
mean frequency of Th1, IFNc+ cells per group 6 SD of 4 mice/group. *p,0.05 as determined by Bonferroni’s modified t-test.
doi:10.1371/journal.pone.0047487.g001
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Figure 2. Disruption of the CXCL13-CXCR5 axis increased UGT pathology. GTs were harvested 49 days after infection and processed en
bloc for paraffin sections. (A) Scatter plot and median of chronic inflammatory scores of BALB/c mice treated with anti-CXCL13 Ab versus an irrelevant
control Ab or C56BL/6 WT mice versus Cxcr52/2 mice from hematoxylin and eosin stained slides. *p,0.05, Mann-Whitney, n = 3–6 mice or 12
oviducts/group. (B) Photomicrograph of trichrome stained sections from oviducts 49 days after infection of C57BL/6 (WT) or Cxcr52/2 mice. Asterisk
(WT) and arrows (Cxcr52/2) show fibrosis and arrowhead (Cxcr52/2) depicts a dilated oviduct. Sections are at 206. (C) Fibrosis scores of C56BL/6 WT
mice and Cxcr52/2 mice from trichrome stained slides. *p,0.01, Mann-Whitney, n = 6 mice or 12 oviducts/group.
doi:10.1371/journal.pone.0047487.g002
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Figure 3. Lymphocytes accumulate in the oviducts of Cxcr52/2 mice following infection. GTs were harvested 49 days after vaginal
infection with C. muridarum and used to isolate lymphocytes from the oviducts. (A) Representative dotplots of oviduct lymphocyte subsets stained
against surface markers and intracellular cytokines. Cells were gated on CD3+CD4+ or CD3+CD8+ cells. (B) The number of lymphocyte subsets as
determined in panel B, were compared between groups. Bars equal the mean 6 SD. *p,0.01 (Bonferroni’s modified t test). n = 3–4 oviduct pools/
group.
doi:10.1371/journal.pone.0047487.g003
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C. muridarum activates iNKT and type II NKT cells and the
lack of NKT cells in Cd1d2/2 mice reduces UGT
pathology
We determined if chlamydial organisms contained antigens
which directly activated iNKT and II NKT cells in a cell-free
system as described [32]. Our analysis found that a C. muridarum
sonicate induced IL-2 secretion and the activation of murine NKT
hybridomas. Figure 5A shows one of two iNKT cell hybridoma
Va14Vb8.2 (1.2, 2C12) and a type II NKT cell hybridoma (19)
[44]. The finding from this assay, which contains only a TCR
ligand presented on CD1d molecules and is free of any antigen
presenting cells, indicates that C. muridarum organisms contain
glycolipid antigens which can bind and activate iNKT and II
NKT cells. It is likely that C. muridarum contains at least 2
glycolipids since type II NKT cells do not recognize iNKT cell
ligands [19]. The increased bacterial burden seen early after
infection in Cxcr52/2 mice (Fig. 1B) could contribute to the
activation of NKT cells. Cd1d2/2 mice, which do not contain
any NKT cells, were given a genital infection with C. muridarum to
determine whether their absence influences oviduct dilation,
fibrosis or bacterial burden in the GT. We found that oviduct
dilation and fibrosis were significantly reduced in mice that lacked
NKT cells (Fig. 5B). Monitoring bacterial burden with vaginal
swabs showed that Cd1d2/2 mice had an increase in bacterial
burden (Fig. 5C) and confirms that NKT cells are involved in C.
muridarum genital infection as previously shown using Cd1d2/2
mice [45].
CXCR5 +10950 T.C (rs3922) correlates with lack of tubal
infertility following C. trachomatis infection in
humans. There is considerable variability in both susceptibility
to acquiring a C. trachomatis infection and development of GT
pathology following infection [36,46,47]. To determine if the
genetic variation in the CXCR5 gene contributes to this variability
in C. trachomatis infected humans we undertook a single-polymor-
phic nucleotide (SNP) analysis for genetic variation in the CXCR5
gene using TaqMan analysis. We examined CXCR5 SNPs in 1940
females from The Netherlands and Finland with chlamydial
genital infection. We analyzed three SNPs in the human CXCR5
gene; +3439 C.T, (rs497916), +9086 T.C, (rs12363277) and
+10950 T.C (rs3922) which tag 96.6% of the haplotypes
spanning 7.6 KB (,41%) of the CXCR5 gene. The distribution
of the SNPs and haplotypes in our study population is shown in
Tables S1 and S2. We evaluated these SNPs for contribution to
the susceptibility of C. trachomatis genital infection by comparing
women attending a STD clinic for potential uncomplicated C.
Figure 4. In vitro depletion of NKT cell function abrogates increased production of IFNc and other cytokines and chemokines in
Cxcr52/2. Lymphocytes were isolated from spleens and treated with various conditions to deplete NKT cells to 95% purity. Cells were cultured with
EB for 3 days. (A) The level of IFNc in cell culture supernatants among groups with the indicated NKT cell depleting/blocking treatment. Each treated
group was compared to its own untreated counterpart using Bonferroni’s modified t test, *p,0.05, **p,0.01, n = 4 mice/group. (B) Multiple cytokines
and chemokines levels were measured in supernatants from a-GalCer depleted plus anti-CD1d treated cell cultures (Depletion+blocking).
doi:10.1371/journal.pone.0047487.g004
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trachomatis infection. As shown in Figure 6A, carriage of CXCR5
+10905 T.C (rs3922) did not differ significantly between women
with and without C. trachomatis genital infection. However, other
alleles did influence susceptibility since carriage of the CXCR5
+9086 T.C (rs12363277) allele was significantly reduced in C.
trachomatis infected women compared to controls (Table S1). C.
trachomatis infected women had a significantly lower frequency of
the CXCR5 haplotype III and a trend of lower frequency in
Figure 5. C. muridarum activates iNKT & type II NKT cells in vitro and in vivo. (A) Various dilutions of C. muridarum sonicate or a-Gal was
added to cultures of type I NKT cell hybridoma 1.2 and a type II NKT cell hybridoma 1.9. IL-2 was measured in triplicate by ELISA. Experiments were
and repeated 2–3 times. (B) Scatter plot of oviduct diameter and fibrosis scores from WT mice and Cxcr52/2 mice obtained from hematoxylin and
eosin and trichrome stained slides, respectively. *p,0.05, Mann-Whitney, n = 6 mice or 12 oviducts/group. (C) Vaginal swabs were collected
throughout the course of infection in WT and Cd1d2/2 mice. *p,0.01 by 2-way repeated measures, n = 6 mice/group.
doi:10.1371/journal.pone.0047487.g005
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CXCR5 haplotype IV compared to CT negative women (Table
S2). These results suggest that women carrying CXCR5 haplotype
III to have reduced severity of C. trachomatis infections while the
CXCR5 +10950 (rs3922) SNP does not contribute to susceptibility
of acquiring a genital infection with C. trachomatis.
We next evaluated whether different variants of the CXCR5
gene correlated with the development of tubal pathology following
chlamydial genital infection. We identified that CXCR5 +10950
T.C (rs3922) was differentially distributed between women who
developed tubal infertility following C. trachomatis infection versus
those that did not following CT infection. Women developing
tubal infertility had a statistically significant decrease in the
frequency of CXCR5 +10950 CC, both in the cohort from the
Netherlands and the cohort from Finland (Fig. 6B). Possessing
CXCR5 SNP +10950 (rs3922) with base pair CC, appears to
protect against development of tubal pathology following infection.
Although the functional consequences, i.e., gain or loss of CXCR5
chemokine function with SNP +10950 T.C (rs3922) is not
known, the data presented here are consistent with the murine
data and suggest that the CXCR5 gene influences chlamydial
genital infection and tubal pathology in humans.
Discussion
We have identified a novel form of immune regulation in the
GT that depends on the chemokine receptor, CXCR5, in mice
and humans. In the absence of this receptor, NKT cell activation
is increased following C. muridarum infection of mice and results in
increased cytokine and chemokine production which could attract
increased numbers of neutrophils and activated cDC to the GT
early after infection. Although Cxcr52/2 mice had increased
chlamydial burden in the GT, equal numbers of EB were used to
activate NKT cells in vitro in WT and Cxcr52/2 mice and there
was still significant NKT cell activation as shown by IFNc
production. Neutrophils have been shown to induce GT
inflammation and fibrosis and although we do not find occlusion
fibrosis, we do find differences in oviduct dilation in the absence of
NKT cells [6,7]. The increased number of activated cDC could
contribute to the increased numbers of T cells found in the
oviducts and increased chronic inflammatory scores measured in
the UGT.. Although CXCR5 is expressed on a subset of NKT
cells (Fig. S1) [48], CXCR5 could be expressed by another cell
type which impacts NKT cell activation and will be investigated in
future studies.
Activation of NKT cells induces numerous functions including
interaction with other cell types as shown in Chlamydia infections
[49]. Our data in Cxcr52/2 mice shows an increase in iNKT cell
activation as defined by expression of CD69. This difference is
confined to activated iNKT cells since we did not find a difference
in the total number of NKT cells between Cxcr52/2 and WT
mice. Also, the lack of CXCR5 did not prevent trafficking of
activated iNKT cells to the GT indicating that CXCR5 is not
Figure 6. Distribution of the CXCR5 SNP+10950 T.C (rs3922) in all three cohorts. Genomic DNA was extracted from peripheral blood.
Distribution of CXCR5 SNP+10950 T.C (rs3922) was determined in samples (A) women with and without a positive C. trachomatis PCR on cervical
swab, n = 543 or (B) women from The Netherlands (n = 56, p: 0.03; OR 0.1, 95%CI: 0.02–0.82) and Finland (n = 114, p: 0.04; OR 0,2; 95%CI: 0.2–0.9) that
were positive for C. trachomatis and clinical evidence of subfertility. Statistics for both groups combined (p: 0.002; OR= 0.1; 95%CI: 0.04–0.5.9) by x2
and Fisher Exact test, (CT: C. trachomatis; TP: Tubal pathology; NL: Netherlands, FIN: Finland.
doi:10.1371/journal.pone.0047487.g006
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present on the subset of NKT cells in the GT or that other
chemokine receptors compensate. In addition, our data imply that
signaling thorough CXCR5 is important for regulating the
activation state and cytokine/chemokine secretion of iNKT cells.
There are precedents for a proposed role for a chemokine receptor
in regulating iNKT cell activity. For example, CXCR6 and its
ligand have been shown to regulate the homeostasis of iNKT cells
in the liver and trafficking to that site was not affected [50].
The presence of CD1d in the GT of humans and the finding
that it is a target of degradation by the chlamydiae CPAF suggests
that NKT cells are important cells to regulate during genital
infection [51,52]. Bilenki, L. et al. [45] showed that activated
iNKT cells enhanced chlamydial growth following infection of the
mouse pathogen, C. muridarum which was reversed in CD1d2/2
mice. They found that activation of iNKT cells induced a Th2-
type cytokine milieu which enhanced C. muridarum lung infection,
delayed eradication of the organism including development of a
Th1 response and induced lung inflammation [45]. These findings
support our work in Cd1d2/2 mice. In contrast, our findings
differed from a study by Wang et. al., which showed that
activation of iNKT with a-GalCer during genital infection
increased production of Th1 cells and slightly reduced bacterial
burden but there was no data on UGT pathology or use of
knockout mice [14]. This can be explained by comparing a-
GalCer stimulation which is not as conclusive as studies in
Ja182/2 mice (target on iNKT cells) and those in Cd1d2/2
mice (target all NKT cell subsets) which target different subsets of
NKT cells. Also, the many subsets of NKT cells may be
functioning at the same time during C. muridarum infection which
additionally confounds the information among various models. We
also found direct evidence that C. muridarum infection activates
iNKT cells and it was recently reported that C. muridarum
glycolipid exoantigen (GLXA) also activated iNKT cells in a
CD1d-cell free assay [13]. Future studies are planned to identify
these antigens using mass spectrophotometric techniques.
CXCR5 is expressed on B cells, T helper follicular cells and
NKT cells [53] which localize in germinal centers and are
important for antibody class switching by conventional or B-2 B
cells [54]. As expected Cxcr52/2 mice given a genital infection
with C. muridarum produce significantly less C. muridarum specific
IgG showing that these mice have defective T-dependent and/or
T-independent antibody production (data not shown). We also
compared the number of CD4 cells in spleens of WT and
Cxcr52/2 to determine whether the lack of CXCR5 impacts the
CD4 cell compartment. The percent of CD4 cells was slightly
increased in Cxcr52/2 mice even before infection and more
profoundly after infection suggesting that although the number of
T helper follicular cells was absent in Cxcr52/2 mice this did not
markedly reduce number of CD4 T cells in the T cell
compartment before and after infection.
This is the first study to provide direct evidence that antigens
contained within chlamydial EB directly activate type II NKT cells
subsets. iNKT and type II NKT cells are activated by C. muridarum
EB suggesting that they contain at least two glycolipid antigens
since iNKT and type II NKT have diverse TCR [55]. After
entering host cells, chlamydiae intercept the host exocytic pathway
and acquire various types of host lipids (phosphatidylinositol,
phosphatidylcholine, cardiolipin and sphingolipids) for incorpora-
tion into bacterial cell walls and inclusion membrane and are
necessary for growth [56–58]. Chlamydiae also contain enzymes
that modify host-derived single chain fatty acids to the microbial
form of branched chain fatty acids [59]. Additional studies have
shown that chlamydiae can synthesize limited phospholipids:
phosphatidylethanolamine, phosphatidylserine and phosphatidyl-
glycerol including a CDP-diacylglycerol [60]. It will be important
to identify chlamydial glycolipids that are presented by CD1d to
define how they influence genital infection.
We have also shown a similar influence of CXCR5 on tubal
pathology in humans. Women carrying the variant allele of CXCR5
+10950 CC did not develop the level of tubal pathology seen in
subfertile women after CT infection. Interestingly, humans with the
CXCR5 SNP+10950 T.C (rs3922), were equally susceptible to C.
trachomatis genital infection compared to carriers of CCR5 SNPs [34].
Other studies have also found a SNP analysis of other chemokine
genes correlates to tubal pathology. Barr et. al., found that the
CCR5-related inflammatory response was demonstrated to be
crucial for the development of tubal factor infertility [34]. They
showed that in women with anti-chlamydial IgG responses, tubal
pathology correlated with a low incidence of functional CCR5D32
deletion (7%), while women without tubal pathology had higher
incidence of the CCR5D32 deletion (31%). Thus, in mice and
humans the inflammation associated with CXCR5 and CCR5
function may predispose to development of complications of
chlamydial infection, such as tubal factor infertility.
The host response is determined by interaction of pathogen-
associated molecular patterns (PAMP) of chlamydiae and compo-
nents of the innate host response. This interaction in turn, is based
on individual genetic variation. Other studies have identified
additional genes which also contribute to the variability in
acquiring a chlamydial infection and immunopathology. Recently,
Bailey et. al. [61] estimated the relative contribution of host
genetics to the total variation in lymphoproliferative responses to
chlamydial antigens by analysing these responses in 64 Gambian
pairs of twins from trachoma-endemic areas. Proliferative
responses to serovar A EB antigens were estimated in monozygotic
and dizygotic twin pairs. They found a stronger correlation and
lower within-pair variability in these responses in monozygotic
compared to dizygotic twin pairs. The heritability estimate was
0.39, suggesting that host genetic factors contributed almost 40%
of the variation. This study reinforces the concept of compiling
genetic traits that influence infection and genital tract pathology
for the development of a sub-fertility risk profile to advance disease
prevention profiles and identify individuals for immune-modula-
tory therapeutics. This approach is currently the focus of
EpiGenChlamydia in Europe.
There is a strong association between repeated C. trachomatis
genital infection and development of tubal inflammation and
infertility [4,5]. A combination of bacterial factors, host factors,
epidemiologic and demographic factors, such as co-infections, and
the mutual interaction of these factors influence this association
[62]. Additionally, there are reported inter-individual differences
in the clinical course of C. trachomatis genital infection such as;
transmission, symptoms, persistence or clearance of infection, and
the development of late complications [4,63,64]. It is difficult to
correlate these to persistence of infection, especially when the
detected serovar is not identical to the previous one [63–66].
Possibly repeated activated of NKT cells with multiple serovars
following chlamydial genital infection in those with altered in
CXCR5 expression and function could be responsible for inter-
individual differences. There is great variability in the frequency of
Va24-Ja18 iNKT cells in the peripheral blood of humans (0.001–
3.0%) and this suggests that differences occur in iNKT cell
development, maturation and/or differentiation [67,68]. It is
possible that frequency and type of infections plus genetic
differences in Cxcr5 gene influence iNKT cell activation in humans
[12]. This knowledge will be beneficial for the design of
therapeutic strategies and vaccine development against Chlamydia
infection.
CXCR5 Regulates Upper Genital Tract Pathology
PLOS ONE | www.plosone.org 11 November 2012 | Volume 7 | Issue 11 | e47487
Our study is the first describing the protective effect of CXCR5
gene polymorphisms in the development of C. trachomatis infection
and late complications of this disease. In this genetically
exploratory study using well defined clinical cohorts and only
one gene, having an in vitro proof of association, we had decided
not to ‘‘overdo’’ by using the most stringent statistical approach.
The additional strength on this study is that our genetic association
is confirmed in a second independent cohort, something which is
in most studies is not even done. As we have shown in the
knockout mouse model, an increased NKT activity leads to an
increased bacterial burden in the GT and late complications of this
disease. In humans, carriage of the variant allele, +10950 T.C,
might result in an altered function of the CXCR5 gene, and thereby
an altered expression of NKT cells thus leading to fewer late
complications of C. trachomatis infections such as tubal pathology. It
is not known if +10950 T.C SNP of CXCR5 gene results in a gain
or loss of function. Although the exact pathways and mechanism(s)
need to be elucidated, Cxcr5 knockout mice appear as a viable
model for understanding the pivotal role of CXCR5. We therefore
hypothesize that in humans, the mechanisms underlying the
course of disease are similar as in Cxcr5 knockout mice. Therefore,
more studies are needed of human CXCR5 genetic polymorphisms
on the function of this chemokine receptor.
Supporting Information
Table S1 Distribution of the CXCR5 SNPs in an STD
cohort from Amsterdam two tubal pathology cohorts.
Genomic DNA was extracted from peripheral blood and PCR was
performed for three CXCR5 SNPs; +3439 C.T (rs497916), +9086
T.C (rs12363277), and +10950 T.C (rs3922). ap:0.0487; OR 0.5,
95%CI: 0.3–1,0; bp: 0.03; OR 0.1, 95%CI: 0.02–0.82; cp: 0.04;
OR 0,2; 95%CI: 0.2–0.9. Groups were compared using x2 and
Fisher Exact test, where appropriate. p,0.05 was considered
statistically significant. CT: C. trachomatis; TP: Tubal pathology.
(PDF)
Table S2 Haplotypes of CXCR5 in in two tubal pathol-
ogy cohorts and an STD cohort from Amsterdam.
Genomic DNA was extracted from peripheral blood and PCR
was performed for three CXCR5 SNPs; +3439 C.T (rs497916),
+9086 T.C (rs12363277) and +10950 T.C (rs3922). CXCR5
haplotypes were inferred using PHASE v2.1.1 [62,63] and
SNPHAP [64]. ap:0.0097, OR: 0.18, 95% CI: 0.05–0.66. Groups
were compared using x2 and Fisher Exact test, where appropriate.
p,0.05 was considered statistically significant. Haplotype IV was
not significantly different from CT- from the FCT: C. trachomatis;
TP: Tubal pathology.
(PDF)
Figure S1 7.5% of NKT cells express CXCR5. Represen-
tative dotplots showing NKT cell gating and expression of
CXCR5, 7 days after infection. Single cell suspensions of
lymphocytes were stimulated with PMA and ionomycin, and
stained for NKT cells using a-GalCer tetramer, CD3, CD4, CD8,
NK1.1, CD69 and CXCR5. Dotplots were gated on CD3+,
NK1.1+, -GalCer-tetramer+ cells.
(TIF)
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